| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |